CLINIBORG
Home
Contents
Recent
Privacy Policy
Terms
About
Metabolic monitoring for atypical antipsychotics
Jan 10, 2015
•
Mark Morgan
categories:
Psychiatry & Psychology
Endocrine, Nutrition & Obesity
Metabolic monitoring for atypical antipsychotics
Note: more comprehensive or frequent monitoring may be needed if chronic medical conditions exist
Baseline
6 weeks after starting drug treatment
12 weeks after starting drug treatment
Annual
<-- Interval
Medical history
Blood pressure
Body mass index
Waist circumference
Fasting glucose level
Fasting lipid levels
Lifestyle counseling
Blood pressure
Body mass index
Fasting glucose level
Fasting lipid levels
Lifestyle counseling
display/hide references
reference:
#1
De Hert M, Vancampfort D, Correll CU, Mercken V, Peuskens J, Sweers K, van Winkel R, Mitchell AJ. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry. 2011 Aug;199(2):99-105.
#2
NIMH - Antipsychotic medications
Calculate The Result!
Reset Form
Result - Copy and paste this output:
Copy to Clipboard
Please enable JavaScript to view the
comments powered by Disqus.